Clinical Trials Directory

Trials / Unknown

UnknownNCT01550029

Targeted Intervention for Bipolar Smokers

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
University of Cincinnati · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research is to develop and test a new type of smoking cessation counseling for individuals with bipolar disorder.

Detailed description

All participants will receive the nicotine patch, an FDA-approved smoking cessation medication, in an open-label fashion. In addition to the nicotine patch, participants will be randomized to receive one of the two types of counseling for smoking cessation. Participants will be in the research study for approximately 18 weeks. The total number of study visits is 15.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCounseling/Healthy LifestyleA trained counselor will meet with subjects for approximately 60 minutes each week during the 12-week treatment period to provide support for quitting and to help develop knowledge and skills for quitting. Also, the National Cancer Institute's "Clearing the Air" guide to smoking cessation will be given to subjects. Some specific areas of focus for this intervention are developing a better understanding of reasons for smoking and the consequences of tobacco use and identifying ways for establishing a healthier lifestyle.
BEHAVIORALCounseling/Managing MoodA trained counselor will meet with subjects for approximately 60 minutes each week during the 12-week treatment period to provide support for quitting smoking and to help develop knowledge and skills for quitting. Also, subjects will receive the National Cancer Institute's "Clearing the Air" guide to smoking cessation. Some specific areas of focus for this intervention are managing negative moods without smoking and overcoming other obstacles to quitting.

Timeline

Start date
2010-07-01
Primary completion
2014-08-01
Completion
2014-08-01
First posted
2012-03-09
Last updated
2014-01-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01550029. Inclusion in this directory is not an endorsement.